Virtus LifeSci Biotech Products ETF
17 hedge funds and large institutions have $10.9M invested in Virtus LifeSci Biotech Products ETF in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$353K | |
| 2 | +$234K | |
| 3 | +$193K | |
| 4 |
SMG
Smart Money Group
Eastland,
Texas
|
+$73.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$34.8K |
Top Sellers
| 1 | -$87.7K | |
| 2 | -$67.8K | |
| 3 | -$11.8K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$3.93K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$721 |